Obstetrics & Gynecology Doctors in Grand Rapids, MN Accepting Medicare

3 Obstetrics & Gynecology doctors found. Showing 1 - 3

Derek A Beyer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1601 Golf Course Rd, Grand Rapids, MN 55744 Phone: 218-326-5000

Dr. Kevin P Gildner, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1601 Golf Course Rd, Grand Rapids, MN 55744 Phone: 218-326-5000

Angela Degrio, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1601 Golf Course Rd, Grand Rapids, MN 55744 Phone: 218-326-3401

News Archive

Human milk antibodies elicited by vaccination show reduced activity against SARS-CoV-2 VoCs

In a study recently published on the medRxiv* preprint server, scientists from Singapore have assessed the levels of IgA-specific anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the breast milk of women recently immunized with the second dose of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine.

Study challenges notion of fear of weight gain in patients with anorexia nervosa

A study from Inserm, Paris Descartes University and Sainte Anne Hospital suggests that anorexia nervosa might not be explained by fear of gaining weight, but by the pleasure of losing it... and that the phenomenon might be genetically influenced.

Medical marijuana hydroponics nutrients receive official US approval

In a landmark decision, Oregon regulators have given first-ever official US approval to a brand of medical marijuana hydroponics nutrients. Oregon and most other states have regulatory agencies that examine fertilizers and hydroponics plant supplements to determine the legitimacy, ingredients and effectiveness of plant growth products.

Molina Healthcare enters into definitive agreement to acquire HIM business of Unisys

Molina Healthcare, Inc. today announced that it has entered into a definitive agreement to acquire the Health Information Management (HIM) business of Unisys Corporation.

ISCO commences second phase of testing RPE derived from parthenogenetic stem cells

International Stem Cell Corporation, announced today that ISCO's Research and Therapeutic Development Group, together with a group of scientists from the University of California, Irvine (UCI), is starting a second phase of essential pre-clinical experiments to test retinal pigment epithelium derived from parthenogenetic stem cells. Follow on pre-clinical experiments will be conducted to rescue vision in disease models.

Read more Medical News

› Verified 1 days ago